Evidence map›Paper›PMID 39525347›Full record

Trial reportCritical care explorations2024

Heterogeneous Treatment Effects of High-Frequency Oscillatory Ventilation for Acute Respiratory Distress Syndrome: A Post Hoc Analysis of the Oscillation for Acute Respiratory Distress Syndrome Treated Early (OSCILLATE) Trial.

Hirotada Kobayashi, Federico Angriman, Niall D Ferguson, Neill K J Adhikari

Abstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Critical care explorations, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hirotada KobayashiDepartment of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.ORCID 0000-0002-9516-6016
Federico AngrimanDepartment of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.ORCID 0000-0003-0971-386X
Niall D FergusonInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-6213-5264
Neill K J AdhikariDepartment of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.ORCID 0000-0003-4038-5382

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe sought to evaluate whether different subgroups of adults with acute respiratory distress syndrome (ARDS) respond differently to high-frequency oscillatory ventilation (HFOV).

designThe Oscillation for ARDS Treated Early (OSCILLATE) trial was a randomized controlled trial of HFOV vs. conventional ventilation that found an increased risk of in-hospital mortality (primary outcome) with HFOV. In a post hoc analysis, we applied three different approaches to evaluate heterogeneity of treatment effect for in-hospital mortality: 1) subgroup analyses based on baseline Pao

settingThirty-nine ICUs, five countries. SUBJECTS: Five hundred forty-eight adults with moderate to severe ARDS.

interventionsHFOV vs. conventional mechanical ventilation with low tidal volume and higher positive end-expiratory pressure. MEASUREMENTS AND MAIN

resultsThe effect of HFOV on in-hospital mortality was consistent across categories of Pao

conclusionsWe did not identify heterogeneity in the effect of HFOV across different subgroups of patients with ARDS.

Indexed as

High-Frequency VentilationHospital MortalityRespiratory Distress SyndromeAdultAgedFemaleHumansIntensive Care UnitsMaleMiddle AgedTreatment Effect HeterogeneityTreatment Outcomeacute respiratory distress syndromehigh-frequency oscillation ventilationlatent class analysisrandomized controlled trialtreatment effect heterogeneity

Identifiers

PMID39525347
PMCPMC11548902

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.